As of 2025-04-25, the Relative Valuation of Travere Therapeutics Inc (TVTX) is (63.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.88 USD, the upside of Travere Therapeutics Inc based on Relative Valuation is -497.5%.
The range of the Relative Valuation is (45.21) - (75.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 25.9x | 18.8x |
| Forward P/E multiples | 11.8x - 20.9x | 16.0x |
| Fair Price | (45.21) - (75.78) | (63.12) |
| Upside | -384.7% - -577.2% | -497.5% |
| Date | P/E |
| 2025-04-21 | -4.24 |
| 2025-04-17 | -4.12 |
| 2025-04-16 | -4.02 |
| 2025-04-15 | -4.12 |
| 2025-04-14 | -4.09 |
| 2025-04-11 | -4.00 |
| 2025-04-10 | -3.72 |
| 2025-04-09 | -3.96 |
| 2025-04-08 | -3.91 |
| 2025-04-07 | -4.19 |
| 2025-04-04 | -4.14 |
| 2025-04-03 | -4.57 |
| 2025-04-02 | -4.95 |
| 2025-04-01 | -4.81 |
| 2025-03-31 | -4.95 |
| 2025-03-28 | -5.43 |
| 2025-03-27 | -5.62 |
| 2025-03-26 | -5.74 |
| 2025-03-25 | -5.80 |
| 2025-03-24 | -5.88 |
| 2025-03-21 | -5.67 |
| 2025-03-20 | -5.75 |
| 2025-03-19 | -5.71 |
| 2025-03-18 | -5.48 |
| 2025-03-17 | -5.76 |
| 2025-03-14 | -5.45 |
| 2025-03-13 | -5.28 |
| 2025-03-12 | -5.32 |
| 2025-03-11 | -5.00 |
| 2025-03-10 | -4.93 |
| 2025-03-07 | -4.99 |
| 2025-03-06 | -5.23 |
| 2025-03-05 | -5.36 |
| 2025-03-04 | -5.44 |
| 2025-03-03 | -5.47 |
| 2025-02-28 | -5.91 |
| 2025-02-27 | -5.70 |
| 2025-02-26 | -5.81 |
| 2025-02-25 | -5.70 |
| 2025-02-24 | -5.86 |
| 2025-02-21 | -6.07 |
| 2025-02-20 | -6.51 |
| 2025-02-19 | -6.44 |
| 2025-02-18 | -6.26 |
| 2025-02-14 | -6.32 |
| 2025-02-13 | -6.55 |
| 2025-02-12 | -6.40 |
| 2025-02-11 | -6.56 |
| 2025-02-10 | -5.83 |
| 2025-02-07 | -6.00 |